文献速递胸部肿瘤放疗

机器学习优化完全切除的III-N2期非小细胞肺癌术后放疗的预后与预测性淋巴结负荷阈值

Machine learning to refine prognostic and predictive nodal burden thresholds for post-operative radiotherapy in completely resected stage III-N2 non-small cell lung cancer.
PubMed 文献 · Radiother Oncol · 2022-05-23

多因素分析中术后放疗与总生存无显著关联(p=0.111),但在阳性淋巴结≥3个亚组(HR 0.91,95%CI 0.86-0.97,p=0.002)和淋巴结比率≥0.34亚组(HR 0.90,95%CI 0.85-0.96,p=0.001)中术后放疗改善总生存。

要点

  • 机器学习确定阳性淋巴结≥3个和淋巴结比率≥0.34为术后放疗获益的阈值。
  • 阳性淋巴结≥3个亚组术后放疗5年OS为38% vs 未放疗31%。
  • 淋巴结比率≥0.34亚组术后放疗5年OS为38% vs 未放疗29%。

核心结论

  • 高淋巴结负荷或高淋巴结比率的患者可能是能从术后放疗中获益的亚群。
  • 据作者所知,这是首项使用机器学习算法结合大型国家数据集探讨该问题的研究。
  • 这些发现涉及胸部肿瘤学领域的一个重要问题,值得在前瞻性研究中进一步探讨。

研究设计与样本

  • 训练基于总生存的机器学习模型,使用SHAP值确定阳性淋巴结数和淋巴结比率的预后与预测阈值。
  • 采用Cox比例风险回归进行验证性分析。

主要发现

  • 通过SHAP值确定阳性淋巴结≥3个和淋巴结比率≥0.34的阈值。
  • 多因素分析中术后放疗与总生存无显著关联(p=0.111)。
  • 阳性淋巴结≥3个亚组中术后放疗改善总生存(HR 0.91,95%CI 0.86-0.97,p=0.002)。
  • 淋巴结比率≥0.34亚组中术后放疗改善总生存(HR 0.90,95%CI 0.85-0.96,p=0.001)。
  • 阳性淋巴结≥3个患者术后放疗5年OS为38%,未放疗为31%;淋巴结比率≥0.34患者术后放疗5年OS为38%,未放疗为29%。

关键数值与推荐

  • 阳性淋巴结数阈值为3个及以上。
  • 淋巴结比率阈值为0.34及以上。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 这些发现值得在前瞻性研究中进一步探讨。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The role of post-operative radiotherapy (PORT) for completely resected N2 non-small-cell lung cancer (NSCLC) is controversial in light of recent randomized data. We sought to utilize machine learning to identify a subset of patients who may still benefit from PORT based on extent of nodal involvement. MATERIALS/METHODS: Patients with completely resected N2 NSCLC were identified in the National Cancer Database. We trained a machine-learning based model of overall survival (OS). SHapley Additive exPlanation (SHAP) values were used to identify prognostic and predictive thresholds of number of positive lymph nodes (LNs) involved and lymph node ratio (LNR). Cox proportional hazards regression was used for confirmatory analysis. RESULTS: A total of 16,789 patients with completely resected N2 NSCLC were identified. Using the SHAP values, we identified thresholds of 3+ positive LNs and a LNR of 0.34+. On multivariate analysis, PORT was not significantly associated with OS (p = 0.111). However, on subset analysis of patients with 3+ positive LNs, PORT improved OS (HR: 0.91; 95% CI: 0.86-0.97; p = 0.002). On a separate subset analysis in patients with a LNR of 0.34+, PORT improved OS (HR: 0.90; 95% CI: 0.85-0.96; p = 0.001). Patients with 3+ positive lymph nodes had a 5-year OS of 38% with PORT compared to 31% without PORT. Patient with positive lymph node ratio 0.34+ had a 5-year OS of 38% with PORT compared to 29% without PORT. CONCLUSIONS: Patients with a high lymph node burden or lymph node ratio may present a subpopulation of patients who could benefit from PORT. To our knowledge, this is the first study to use machine learning algorithms to address this question with a large national dataset. These findings address an important question in the field of thoracic oncology and warrant further investigation in prospective studies.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Zarinshenas R, Ladbury C, McGee H, et al. Machine learning to refine prognostic and predictive nodal burden thresholds for post-operative radiotherapy in completely resected stage III-N2 non-small cell lung cancer. Radiother Oncol. 2022. PMID: 35618098. doi:10.1016/j.radonc.2022.05.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。